Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elisa Funck-Brentano
Increase inNRASmutant Allele Percentage During Metastatic Melanoma Progression
Experimental Dermatology
Biochemistry
Dermatology
Molecular Biology
Pembrolizumab and Concurrent Hypo-Fractionated Radiotherapy for Advanced Non-Resectable Cutaneous Squamous Cell Carcinoma
European Journal of Dermatology
Dermatology
Related publications
DistinctMHCgene Expression Patterns During Progression of Melanoma
Genes Chromosomes and Cancer
Cancer Research
Genetics
Angiopoietin-2 Levels Are Associated With Disease Progression in Metastatic Malignant Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Genetic Alterations in Main Candidate Genes During Melanoma Progression
Oncotarget
Oncology
Targeting Metastatic Melanoma
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
Pembrolizumab-Induced Sarcoid-Like Reactions During Treatment of Metastatic Melanoma
Radiology
Nuclear Medicine
Radiology
Imaging
WNT5A Expression Increases During Melanoma Progression and Correlates With Outcome
Clinical Cancer Research
Cancer Research
Oncology
Overall and Progression-Free Survival in Metastatic Melanoma: Analysis of a Single-Institution Database
Cancer Control
Medicine
Oncology
Hematology
Metastatic Melanoma and Pregnancy
Archive of Oncology
Oncology
Hematology
Cutaneous CD56 + T-Cell Lymphoma Developing During Pembrolizumab Treatment for Metastatic Melanoma
JAAD Case Reports
Dermatology